Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Brainstorm Cell Therapeutics Inc. (BCLI)

  • Technical Exchange News
  • July 18, 2025, 01:33 UTC
  • 3

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Brainstorm Cell Therapeutics Inc. (BCLI)

  • Technical Exchange News
  • July 18, 2025, 00:52 UTC
  • 2

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Brainstorm Cell Therapeutics Inc. - Common Stock.

Comment Full text

Brainstorm Cell Therapeutics Inc. (BCLI)

  • Technical Exchange News
  • July 18, 2025, 00:52 UTC
  • 1

NASDAQ traded attribute type Security_Name was changed. Previous value: Brainstorm Cell Therapeutics Inc. - Common Stock. New value: Brainstorm Cell Therapeutics Inc. - Common Stock.

Comment Full text

iCAD Inc. (ICAD)

  • Technical Exchange News
  • July 18, 2025, 00:52 UTC
  • 2

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: icad inc. - Common Stock.

Comment Full text

Brainstorm Cell Therapeutics Inc. (BCLI)

  • Technical Exchange News
  • July 18, 2025, 00:52 UTC
  • 2

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Brainstorm Cell Therapeutics Inc. - Common Stock.

Comment Full text

iCAD Inc. (ICAD)

  • Technical Exchange News
  • July 18, 2025, 00:52 UTC
  • 3

NASDAQ traded attribute type Security_Name was changed. Previous value: icad inc. - Common Stock. New value: icad inc. - Common Stock.

Comment Full text

iCAD Inc. (ICAD)

  • Technical Exchange News
  • July 18, 2025, 00:52 UTC
  • 1

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: icad inc. - Common Stock.

Comment Full text

Inspira Technologies Oxy BHN (IINN)

  • Technical Exchange News
  • July 17, 2025, 18:40 UTC
  • 3

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Brainstorm Cell Therapeutics Inc. (BCLI)

  • Technical Exchange News
  • July 17, 2025, 18:40 UTC
  • 3

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

DELEK PROP (DLPR)

  • Technical Exchange News
  • July 17, 2025, 17:30 UTC
  • 3

DELEK PROP (DLPR) was added to the list of traded instruments on TASE exchange

Comment Full text
  • Previous
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Search

News categories

  • Technical Exchange News(9632)
  • Event(407)
  • SEC News(157952)
  • FDA Approval(9094)
  • Company Report(721)
  • Business News(107210)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin